USPTO serial 79265913
ACTICOR
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 26, 2021
- Examiner
- CIANCI, RYAN MICHAEL
- Law office
- TMO LAW OFFICE 116
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with ACTICOR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*
Plus Government fees of $975
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Pina M. Campagna
Pina M. Campagna Carter, DeLuca, & Farrell, LLP576 Broad Hollow Rd.Melville, NY 11747UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Monoclonal antibodies for scientific use; [ reagents for scientific or medical research use; biochemicals for in vitro and in vivo scientific use and medical research use; ] biological preparations * of monoclonal antibodies * for use in industry and science [ ; proteins in raw material form for use in scientific research ] | ACTIVE | — |
| 005 | Antibodies in the form of biological preparations for the prevention and treatment of arterial and venous thrombosis, restenosis, and thromboembolic diseases; pharmaceuticals for prevention and treatment of arterial and venous thrombosis, restenosis, and thromboembolic diseases; pharmaceutical preparations and substances prevention and treatment of arterial and venous thrombosis, restenosis, and thromboembolic diseases | ACTIVE | — |
| 042 | [ Medical and scientific laboratory services relating to the production of antibodies; ] biotechnological and pharmaceutical drug development services; pharmaceutical and biotechnological research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development in the pharmaceutical and biotechnology fields | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ACTICOR BIOTECH
- Other trademarks owned by ACTICOR BIOTECH
- Other trademarks owned by ACTICOR BIOTECH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named ACTICOR
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 26, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| May 23, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 28, 2021 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Apr 28, 2021 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Apr 26, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 28, 2021 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| Jan 28, 2021 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Jan 26, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 17, 2020 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Dec 11, 2020 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Jul 9, 2020 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jun 9, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 9, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 5, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 20, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 20, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 20, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 7, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 4, 2020 | ALIE | ASSIGNED TO LIE | — |
| Apr 27, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 27, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 27, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 27, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 27, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 7, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 7, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 7, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 2, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 17, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 17, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 2, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 1, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 23, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 4, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 31, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 22, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |